Related Experiment Video
Updated: May 12, 2026
10:38
Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
Published on: January 15, 2018
Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application
Klaus Pollinger1, Robert Hennig, Andreas Ohlmann
1Department of Pharmaceutical Technology, University of Regensburg, 93040 Regensburg, Germany.
Summary
Researchers developed targeted nanoparticles for posterior eye diseases. These nanoparticles bind specifically to retinal capillary cells, offering a safer alternative to current treatments and improving drug delivery to the back of the eye.
Area of Science:
- Ophthalmology
- Nanotechnology
- Biomedical Engineering
Background:
- Current treatments for posterior eye diseases involve laser photocoagulation and intraocular injections, which can damage healthy tissue and cause complications.
- Developing targeted therapies is crucial to overcome the limitations of existing treatments and improve patient outcomes.
Purpose of the Study:
- To investigate the feasibility of using receptor-mediated nanoparticle targeting for posterior eye diseases.
- To evaluate the specificity and efficacy of targeted nanoparticles in reaching retinal capillary endothelial cells after intravenous administration.
Main Methods:
- Utilized cyclo(RGDfC)-modified quantum dots for targeted delivery.
- Conducted cell-binding studies with microvascular endothelial cells, Mueller cells, and astrocytes.
- Performed in vivo experiments in nude mice to assess nanoparticle distribution in the retina.
Main Results:
- Quantum dots demonstrated receptor-specific binding and cellular uptake via the αvβ3 integrin receptor in endothelial cells.
- Off-target cells (Mueller cells, astrocytes) showed negligible interaction with the nanoparticles.
- In vivo studies confirmed significant accumulation of targeted nanoparticles in the choriocapillaris and intraretinal capillaries, while non-targeted nanoparticles did not.
Conclusions:
- Receptor-mediated nanoparticle targeting of integrin receptors in the retina is a feasible strategy for treating posterior eye pathologies.
- This approach offers a promising, less invasive alternative to current treatments, potentially improving therapeutic interventions for difficult-to-access eye conditions.
